Description
SLU-PP-332 5MG supplied by PureTy Peptides for qualified laboratory buyers. Modality: Injectable; presentation: 5MG.
Areas of research interest
- Treating metabolic diseases (obesity & diabetes)
- Addressing muscle-wasting syndromes (cardiovascular conditions)
- Neurodegenerative disorders (Alzheimer’s, etc)
- Activating estrogen-related receptors that regulate metabolism and fat oxidation
Specifications
- Modality: Injectable
- Presentation: 5MG
- Purity target: ≥99% (batch-specific COA available on request)
For research use only. Not for human or animal use.
Reviews
There are no reviews yet.